Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
28 January 2020 | Story Rulanzen Martin | Photo Pexels
Conference
At the meet-and-greet last night, were from left Prof Ruad Ganzevoort, Diversity Officer and Dean of Theology and Religion at VUA, Prof Francis Petersen and Dr Gene Block, Chancellor of UCLA.

The Unit for Institutional Change and Social Justice at the University of the Free State (UFS) is hosting a colloquium on Fragility and Resilience: Facets, Features and Transformation in Higher Education which started on 29 January, with the official progamme concluding on 30 January 2020.

The colloquium is a annual collaborative partnership between the UFS, University of California, Los Angeles (UCLA), and the Vrije Universiteit Amsterdam (VUA).

Apart from the overarching themes the colloquium also placed some focus on mental health, within this context as all three regions are witnessing a spike in mental health issues among students and staff as well as a deficit in terms of being able to sufficiently address the crisis.

“All three universities are committed to discussing global developments in diversity and transformation in higher education to discussing global developments in diversity and transformation as it may constitute itself in higher education circles around the globe,” says Dr Dionne van Reenen, convener of the 2020 colloquium and research fellow at the unit.  

The idea is to discuss what has and has not worked and, hopefully, access best practices in a variety of contexts. The partnership between the three universities spans over six years starting in 2014 when the UFS first hosted the research colloquium. It is the third time the UFS has hosted the colloquium.
 
Prof Francis Petersen, Rector and Vice-Chancellor of the UFS, along with other members of the UFS Rectorate, attended a meet-and-greet on Monday 28 January 2020, and was joined by Dr Gene Block, Chancellor of UCLA, Vice Provosts Cindy Fan, Patricia Turner, Charles Alexander, Professors Abel Valenzuela, John Hamilton and Dr Shalom Staub, director of Community Learning, as well as Prof Ruard Ganzevoort, Chief Diversity Officer and Dean of Theology and Religion at VUA 

News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept